Genmab — April 2021
-
23:43 -omtalte artikel på engelsk = CD38 in the Age of Covid-19: a Medical Perspective. https://journals.physiology.org/doi/abs/10.1152/physrev.00046.2020
-
Of clinical relevance for the future in the strategy to fight COVID-19 is the identification of
molecular metabolic pathways generally usurped by the viral pathogen and addressing the evaluation
of the impact of agents that selectively target CD38’s receptorial and catalytic activities to confirm the
potential of CD38 as a novel therapeutic target. -
i am not even sure it would be a good thing , commercially, if Dara would be a usefull drug for Covid; at what price would that be acceptable? it would be impossible to charge $100,000 for that... so how would that work, charging a few 1,000 for covid drug while charging > 100,000 for the same in cancer?
-
It’s never been proven - but I have strong suspicion that quite a few analysts have it as their strongest analysis assumption their target can never be to far from the current stock price...
-
-
Link til selve tråden https://www.proinvestor.com/boards/89730#postdiv91872
-
-
@E L herding - it is a strange thing and so deeply embedded in our nature
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind